S838 Health-Related Quality of Life in Patients With One Prior Episode of Recurrent Clostridioides difficile Infection (rCDI): Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled rCDI Trial (PUNCH CD3)
暂无分享,去创建一个
K. Garey | E. Dubberke | A. Guo | M. Fillbrunn | V. Garcia-Horton | Min Yang | Adam J Harvey | G. Tillotson | Jonathan Salcedo | Lindy L. Bancke